Scientists probe immune system clues in panic disorder
NCT ID NCT07444879
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at whether certain immune system markers (IL-33, sST2, and CRP) are different in people with panic disorder compared to healthy individuals. Researchers will measure these markers in blood samples from 80 participants who have never taken medication for panic disorder. The goal is to better understand the role of inflammation in panic disorder, not to test a treatment.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
About 80 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Jul 2025
- Expected to finish
-
Mar 2026
An estimate. End dates often move.
- Lead sponsor
-
A government agency
The lead sponsor is a government body.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
The study population consisted of adult participants aged 18-65 years. The panic disorder (PD) group included consecutive subjects diagnosed with PD according to DSM-5-TR criteria who were admitted to the psychiatry clinic of Elazığ Mental Health and Diseases Hospital (Turkey). The healthy control (HC) group consisted of individuals from the general population who applied to the hospital medical board and had no current or past psychiatric or significant medical disorders. All participants provided informed consent prior to enrollment.
- Ages
-
18 to 65 years
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
1. For Panic Disorder (PD) Group: \*Inclusion Criteria: * Being between 18-65 years of age * Having a diagnosis of panic disorder (PD) according to DSM-5-TR and having presented to the hospital with panic attack symptoms of the disorder * Not having previously used any medication for psychiatric purposes (drug-naive) * Not having any additional active psychiatric disorders besides PD at the current presentation * Absence of hypertension, diabetes mellitus, renal failure, hepatic failure, neurological disease with cognitive impairment, acute infection, pregnancy, autoimmune disease, or cancer * Not having taken any medication or supplements in the last month * Completing sociodemographic and scale data fully * Volunteering to participate in the study For PD Group: \*Exclusion Criteria: • Being outside the 18-65 age range • Not meeting the diagnostic criteria for PD according to DSM-5-TR or being in good health • Having a history of psychiatric medication use • Having an additional psychiatric disorder besides PD at the current application • Presence of hypertension, diabetes mellitus, renal failure, hepatic failure, neurological disease with cognitive impairment, acute infection, pregnancy, autoimmune disease, cancer • Patients with a body mass index (BMI) \<18.5 kg/m² and \>29.9 kg/m² * Taking any medication or supplement in the last month * Incomplete completion of sociodemographic and scale data * Not volunteering to participate in the study 2. For Healthy Control Group: * Inclusion Criteria: * Being between 18-65 years of age * Not having any active psychiatric disorder * Not having previously used any medication for psychiatric purposes (drug-naive) * Not having hypertension, diabetes mellitus, kidney failure, liver failure, neurological disease with cognitive impairment, acute infection, pregnancy, autoimmune disease, or cancer * Not having taken any medication or supplement in the last month * Completing sociodemographic and scale data fully * Volunteering to participate in the study For Healthy Control Group: \*Exclusion Criteria: * Being outside the 18-65 age range * Having any active psychiatric disorder * Having a history of using psychiatric medication * Having hypertension, diabetes mellitus, renal failure, hepatic failure, neurological disease with cognitive impairment, acute infection, pregnancy, autoimmune disease, or cancer * Patients with a body mass index (BMI) \< 18.5 kg/m² and \> 29.9 kg/m² * Taking any medication or supplement in the last month * Incomplete completion of sociodemographic and scale data * Not volunteering to participate in the study
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Panic disorder are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Elazığ Mental Health and Diseases Hospital Psychiatry Clinic
RECRUITINGElâzığ, Elâzığ, 23200, Turkey (Türkiye)
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can tailored brain stimulation quiet anxiety that drugs Can't?
- Rewriting traumatic panic memories: a new therapy on trial
- Can rewiring fear expectations stop anxiety from coming back?
- Can an AI coach help therapists treat depression and anxiety online?
- Can a unified therapy tame both addiction and emotional disorders?
- Can online therapy or parent coaching ease childhood anxiety? a head-to-head trial aims to find out.